Table Of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	32
2.4 Emerging Opportunities and Market Trends	35
2.5 Porter’s Fiver Forces Analysis	39
3 Segmentation of North America Market by Drug Type	43
3.1 Market Overview by Drug Type	43
3.2 Small Molecule Drugs	45
3.3 Biologic Drugs	46
4 Segmentation of North America Market by Service	47
4.1 Market Overview by Service	47
4.2 Medicinal Chemical Services	49
4.3 Biological Services	50
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services	51
4.5 Other Pharmaceutical Services	52
5 Segmentation of North America Market by Process	53
5.1 Market Overview by Process	53
5.2 Target Selection	55
5.3 Target Validation	56
5.4 Hit-To-Lead Identification	57
5.5 Lead Optimization	58
5.6 Candidate Validation	59
6 Segmentation of North America Market by Technology	60
6.1 Market Overview by Technology	60
6.2 High Throughput Screening	62
6.3 Combinatorial Chemistry	63
6.4 Pharmacogenomics and Pharmacogenetics	64
6.5 Nanotechnology	65
6.6 Bioanalytical Instruments	66
6.7 Biochips	67
6.8 Bioinformatics	68
6.9 Other Technologies	69
7 Segmentation of North America Market by Therapeutic Area	70
7.1 Market Overview by Therapeutic Area	70
7.2 Oncology	72
7.3 Neurology	73
7.4 Infectious and Immune System Diseases	74
7.5 Digestive System Diseases	75
7.6 Cardiovascular Diseases	76
7.7 Diabetes	77
7.8 Respiratory Disease	78
7.9 Other Therapeutic Areas	79
8 Segmentation of North America Market by End User	80
8.1 Market Overview by End User	80
8.2 Pharmaceutical Companies	82
8.3 Contract Research Organizations (CROs)	83
8.4 Research Institutes	84
8.5 Other End Users	85
9 North America Market 2019-2030 by Country	86
9.1 Overview of North America Market	86
9.2 U.S.	89
9.3 Canada	95
9.4 Mexico	97
10 Competitive Landscape	99
10.1 Overview of Key Vendors	99
10.2 New Product Launch, Partnership, Investment, and M&A	102
10.3 Company Profiles	103
Abbott Laboratories Inc.	103
Agilent Technologies Inc.	105
Astrazeneca plc	106
Bayer AG	107
Charles River Laboratories International Inc.	108
Eli Lilly and Company	109
F. Hoffmann-La Roche Ltd	110
GlaxoSmithKline PLC	111
Merck & Co. Inc.	112
Novartis AG	113
Pfizer Inc.	114
Shimadzu Corp	115
Thermo Fisher Scientific Inc.	116
RELATED REPORTS	117

List Of Tables:

Table 1.  Snapshot of North America Drug Discovery Market in Balanced Perspective, 2019-2030	17
Table 2. Growth Rate of World GDP, 2020-2022	21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn	27
Table 4. World Health Spending by Region, $ bn, 2013-2020	30
Table 5. Total Number of Registered Clinical Studies Worldwide, 2010-2019	31
Table 6.  Main Product Trends and Market Opportunities in North America Drug Discovery Market	35
Table 7. North America Drug Discovery Market by Drug Type, 2019-2030, $ mn	43
Table 8. North America Drug Discovery Market by Service, 2019-2030, $ mn	47
Table 9. North America Drug Discovery Market by Process, 2019-2030, $ mn	53
Table 10. North America Drug Discovery Market by Technology, 2019-2030, $ mn	60
Table 11. North America Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn	70
Table 12. North America Drug Discovery Market by End User, 2019-2030, $ mn	80
Table 13. North America Drug Discovery Market by Country, 2019-2030, $ mn	87
Table 14. U.S. Drug Discovery Market by Drug Type, 2019-2030, $ mn	91
Table 15. U.S. Drug Discovery Market by Service, 2019-2030, $ mn	91
Table 16. U.S. Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn	91
Table 17. Novel Drug Approvals in U.S. in 2020	92
Table 18. Canada Drug Discovery Market by Drug Type, 2019-2030, $ mn	96
Table 19. Canada Drug Discovery Market by Service, 2019-2030, $ mn	96
Table 20. Canada Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn	96
Table 21. Mexico Drug Discovery Market by Drug Type, 2019-2030, $ mn	98
Table 22. Mexico Drug Discovery Market by Service, 2019-2030, $ mn	98
Table 23. Mexico Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn	98
Table 24. Abbott Laboratories Inc.: Company Snapshot	103
Table 25. Abbott Laboratories Inc.: Business Segmentation	103
Table 26. Abbott Laboratories Inc.: Product Portfolio	104
Table 27. Abbott Laboratories Inc.: Revenue, 2018-2020, $ mn	104

List Of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	16
Figure 4. North America Drug Discovery Market, 2019-2030, $ mn	19
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of North America Drug Discovery Market	25
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	29
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	29
Figure 9. Primary Restraints and Impact Factors of North America Drug Discovery Market	32
Figure 10. Investment Opportunity Analysis	36
Figure 11. Porter’s Fiver Forces Analysis of North America Drug Discovery Market	39
Figure 12. Breakdown of North America Drug Discovery Market by Drug Type, 2019-2030, % of Revenue	44
Figure 13. North America Addressable Market Cap in 2021-2030 by Drug Type, Value ($ mn) and Share (%)	44
Figure 14. North America Drug Discovery Market by Drug Type: Small Molecule Drugs, 2019-2030, $ mn	45
Figure 15. North America Drug Discovery Market by Drug Type: Biologic Drugs, 2019-2030, $ mn	46
Figure 16. Breakdown of North America Drug Discovery Market by Service, 2019-2030, % of Sales Revenue	48
Figure 17. North America Addressable Market Cap in 2021-2030 by Service, Value ($ mn) and Share (%)	48
Figure 18. North America Drug Discovery Market by Service: Medicinal Chemical Services, 2019-2030, $ mn	49
Figure 19. North America Drug Discovery Market by Service: Biological Services, 2019-2030, $ mn	50
Figure 20. North America Drug Discovery Market by Service: Drug Metabolism and Pharmacokinetics (DMPK) Services, 2019-2030, $ mn	51
Figure 21. North America Drug Discovery Market by Service: Other Pharmaceutical Services, 2019-2030, $ mn	52
Figure 22. Breakdown of North America Drug Discovery Market by Process, 2019-2030, % of Sales Revenue	54
Figure 23. North America Addressable Market Cap in 2021-2030 by Process, Value ($ mn) and Share (%)	54
Figure 24. North America Drug Discovery Market by Process: Target Selection, 2019-2030, $ mn	55
Figure 25. North America Drug Discovery Market by Process: Target Validation, 2019-2030, $ mn	56
Figure 26. North America Drug Discovery Market by Process: Hit-To-Lead Identification, 2019-2030, $ mn	57
Figure 27. North America Drug Discovery Market by Process: Lead Optimization, 2019-2030, $ mn	58
Figure 28. North America Drug Discovery Market by Process: Candidate Validation, 2019-2030, $ mn	59
Figure 29. Breakdown of North America Drug Discovery Market by Technology, 2019-2030, % of Revenue	61
Figure 30. North America Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%)	61
Figure 31. North America Drug Discovery Market by Technology: High Throughput Screening, 2019-2030, $ mn	62
Figure 32. North America Drug Discovery Market by Technology: Combinatorial Chemistry, 2019-2030, $ mn	63
Figure 33. North America Drug Discovery Market by Technology: Pharmacogenomics and Pharmacogenetics, 2019-2030, $ mn	64
Figure 34. North America Drug Discovery Market by Technology: Nanotechnology, 2019-2030, $ mn	65
Figure 35. North America Drug Discovery Market by Technology: Bioanalytical Instruments, 2019-2030, $ mn	66
Figure 36. North America Drug Discovery Market by Technology: Biochips, 2019-2030, $ mn	67
Figure 37. North America Drug Discovery Market by Technology: Bioinformatics, 2019-2030, $ mn	68
Figure 38. North America Drug Discovery Market by Technology: Other Technologies, 2019-2030, $ mn	69
Figure 39. Breakdown of North America Drug Discovery Market by Therapeutic Area, 2019-2030, % of Revenue	71
Figure 40. North America Addressable Market Cap in 2021-2030 by Therapeutic Area, Value ($ mn) and Share (%)	71
Figure 41. North America Drug Discovery Market by Therapeutic Area: Oncology, 2019-2030, $ mn	72
Figure 42. North America Drug Discovery Market by Therapeutic Area: Neurology, 2019-2030, $ mn	73
Figure 43. North America Drug Discovery Market by Therapeutic Area: Infectious and Immune System Diseases, 2019-2030, $ mn	74
Figure 44. North America Drug Discovery Market by Therapeutic Area: Digestive System Diseases, 2019-2030, $ mn	75
Figure 45. North America Drug Discovery Market by Therapeutic Area: Cardiovascular Diseases, 2019-2030, $ mn	76
Figure 46. North America Drug Discovery Market by Therapeutic Area: Diabetes, 2019-2030, $ mn	77
Figure 47. North America Drug Discovery Market by Therapeutic Area: Respiratory Disease, 2019-2030, $ mn	78
Figure 48. North America Drug Discovery Market by Therapeutic Area: Other Therapeutic Areas, 2019-2030, $ mn	79
Figure 49. Breakdown of North America Drug Discovery Market by End User, 2019-2030, % of Revenue	80
Figure 50. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)	81
Figure 51. North America Drug Discovery Market by End User: Pharmaceutical Companies, 2019-2030, $ mn	82
Figure 52. North America Drug Discovery Market by End User: Contract Research Organizations (CROs), 2019-2030, $ mn	83
Figure 53. North America Drug Discovery Market by End User: Research Institutes, 2019-2030, $ mn	84
Figure 54. North America Drug Discovery Market by End User: Other End Users, 2019-2030, $ mn	85
Figure 55. Breakdown of North America Drug Discovery Market by Country, 2019 and 2030, % of Revenue	87
Figure 56. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)	88
Figure 57. U.S. Drug Discovery Market, 2019-2030, $ mn	90
Figure 58. Canada Drug Discovery Market, 2019-2030, $ mn	95
Figure 59.  Drug Discovery Market in Mexico, 2019-2030, $ mn	97
Figure 60. Growth Stage of North America Drug Discovery Industry over the Forecast Period	99

Key Players (this may not be a complete list and extra companies can be added upon request): 
Abbott Laboratories Inc.
Agilent Technologies Inc.
Astrazeneca plc
Bayer AG
Charles River Laboratories International Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Shimadzu Corp
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)